SCHEMBL19203397

SCHEMBL19203397

Cc1cccc(C(C)I)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.46
▸ ADRA2A P08913 4/20 0.46
▸ ADRA2B P18089 4/20 0.46
▸ ADRA2C P18825 4/20 0.46
▸ CYP1A2 P05177 4/20 0.46
▸ ADRA1A P35348 3/20 0.46
▸ ADRA1B P35368 3/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ ADRA1D P25100 2/20 0.46
▸ KCNH2 Q12809 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ SLC6A2 P23975 2/20 0.44
▸ HTR7 P34969 1/20 0.44
▸ TRPA1 O75762 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ ESR1 P03372 1/20 0.38
▸ CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1053969 0.82 TSHR (0.55) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL20862729 0.81 LMNA (0.46) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL23621891 0.80 ESR1 (0.52) TSHRADRA2AADRA2BADRA2CADRA1A
SCHEMBL196657 0.80 TSHR (0.50) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL7331227 0.80 ESR1 (0.52) TSHRADRA2AADRA2BADRA2CADRA1A
SCHEMBL15694230 0.79 S1PR1 (0.41) TSHRADRA2AADRA2BADRA2CCYP1A2
Hydrochloric Acid SCHEMBL28185848 0.78 ADRA2A (0.50) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL629239 0.77 TRPA1 (0.46) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL13263921 0.76 TRPA1 (0.46) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL7751159 0.76 CYP1A2 (0.48) TSHRADRA2AADRA2BADRA2CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017132173-A1 MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE REGENERON PHARMACEUTICALS, INC. (US) 2017-08-03 — — WO disclosed
Send feedback